ANTH. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE) http://finance.yahoo.com/news/anthera-announces-advancement-blisibimod-phase-120000246.html stockcharts.com/c-sc/sc?s=ANTH&p=D&yr=0&mn=3&dy=0&i=t47928136295&r=1347884064751